Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Celleron licenses cancer drug emactuzumab from Roche

pharmaceutical-technologyAugust 14, 2020

Tag: Roche , Celleron , emactuzumab

PharmaSources Customer Service